Bid Price | 2.12p | High Price | 2.37p |
---|
Ask Price | 2.22p | Low Price | 2.12p |
---|
Open Price | 2.16p | Spread | 4.50% |
---|
Prev Close | 2.25p | Volume | 909,078 |
---|
Immupharma PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Jul 4, 2025 | 2.16 | 2.37 | 2.12 | 2.17 | 909,078 |
Jul 3, 2025 | 2.10 | 2.47 | 2.10 | 2.25 | 1,167,250 |
Jul 2, 2025 | 2.35 | 2.35 | 2.10 | 2.18 | 1,072,280 |
Jul 1, 2025 | 2.38 | 2.38 | 2.13 | 2.22 | 1,415,556 |
Jun 30, 2025 | 2.36 | 2.36 | 2.26 | 2.30 | 1,417,763 |
More Immupharma PLC Historic Prices >Immupharma PLC Information
Name | Immupharma PLC | Index | FTSE AIM All Share |
---|
ISIN | GB0033711010 | Epic | IMM |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | AMSM |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 150,000 | Trading Status | Closed |
---|
Shares in Issue | 416.44 m | Prev Close | 2.25p |
---|
PE Ratio | | Market Cap | £9.04 m |
---|
Div Yield | 0 | Div per Share | £NaN |
---|
EPS | -£0.01 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | -1.803387 | DPS Growth (%) | 0 |
---|
Current Ratio | 0.5822 | Quick Ratio | 0.28066 |
---|
Immupharma PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
07/09/23 | BUY | Lisa Baderoon | NED | 1,000,000 @ £0.02 | £20,000.00 |
11/08/22 | BUY | Timothy McCarthy | CH | 1,200,000 @ £0.05 | £60,000.00 |
11/08/22 | BUY | Timothy Franklin | ED | 400,000 @ £0.05 | £20,000.00 |
11/08/22 | BUY | Lisa Baderoon | NED | 400,000 @ £0.05 | £20,000.00 |
24/08/21 | BUY | Timothy Franklin | ED | 125,000 @ £0.08 | £9,988.00 |
24/08/21 | BUY | Timothy McCarthy | CH | 250,000 @ £0.08 | £20,650.00 |
30/03/20 | PLAC | Robert Zimmer | RES | 2,000,000 @ £0.10 | £200,000.00 |
05/02/16 | PLAC | Franco Muzio | RES | 38,462 @ £0.26 | £10,000.00 |
05/02/16 | PLAC | Timothy McCarthy | CH | 38,462 @ £0.26 | £10,000.00 |
05/02/16 | PLAC | Dimitri Dimitriou | RES | 38,462 @ £0.26 | £10,000.00 |
More Immupharma PLC Director Deals >Immupharma PLC News